All Treatments

Stelara

Stelara (ustekinumab) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation. Specifically it is an interleukin-12 and -23 antagonist antibody, used to treat psoriasis Crohn’s disease and Ulcerative Colitis (UC).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Janssen Biotech

CLASS:
Biologics
WHAT IT TREATS:
  • Moderate to severe Plaque Psoriasis
  • Active Psoriatic Arthritis alone or combination with Methotrexate
  • Moderate to severe Crohn’s disease and Ulcerative Colitis (UC)
PRESCRIBED BY:
  • Dermatologists
  • Gastroenterologists
HOW ADMINISTERED:
Subcutaneous injection or intravenous infusion, or a combination of both (depending on the diagnosis).
FREQUENCY:

For psoriasis, every 12 weeks (after two starter doses); For UC and Crohn’s disease, every 8 weeks (after an IV starter dose).

Length of infusion:
10 minutes or less for subcutaneous injection; about an hour for IV infusion
RELATED DRUGS:
FOR MORE INFORMATION:
Follow a manual added link

855.478.1528

Our mission is to provide clinically exceptional, compassionate, convenient, and cost-effective infusion care to improve the health of our patients in partnership with their physicians

Our vision is to set the nationally recognized standard for the delivery of innovative therapeutics in a patient-friendly environment

CORPORATE OFFICE
1726 Cole Blvd. Suite 250
Lakewood, CO 80401

Find A Location
Refer A Patient
©2022 VIVO Infusion. All Rights Reserved. Website by MANTIKI Creative.
PRIVACY POLICY
Solu MedrolTepezza